Understanding gut microbial imbalance in pancreatic cancer development and treatment
Pancreatic ductal adenocarcinoma (PDAC) is recognized as one of the most lethal cancers, with an estimated five-year survival rate of approximately 10%.
Nasal spray could treat Alzheimer’s disease
Researchers are exploring a new therapy to delay the progression of Alzheimer's disease. It could be delivered in the form of a nasal spray.
Could vitamin D help COVID-19 patients? Meta-analysis highlights potential ICU reduction
Vitamin D may lower ICU and intubation rates in COVID-19 patients, with significant benefits observed in older and severe cases, according to recent research.
Study links tanning bed use to rising melanoma rates in New England
Melanoma accounts for only 1% of skin cancers in the United States but results in the largest number of skin cancer deaths. Investigators evaluated the potential link between the availability and use of tanning beds and the rising rates of melanoma in New England.
Emerging therapies transform autoimmune hepatitis treatment approaches
Autoimmune hepatitis (AIH) is a chronic, progressive liver disease caused by immune system dysregulation that targets the liver. If untreated, AIH can lead to severe complications, including cirrhosis and liver failure.
The global challenge of weight-related issues in kidney disease
A new nationwide study from Japan spanning a 14 year study period has revealed an increasing trend of overweight and obesity in patients with the incident end-stage kidney disease (ESKD).
Cachexia diagnosis criteria affect cancer patient survival rates
Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with advanced cancer.
Study links nasal autoantibodies to COVID-19 severity prediction
A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially greater risk of severe disease.
Multitarget stool DNA test shows promise for early colorectal cancer detection
A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting colorectal cancer (CRC) among Thai individuals.
last updated on 7 Nov 19:47